KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Gains from Sales and Divestitures (2016 - 2019)

Historic Gains from Sales and Divestitures for Incyte (INCY) over the last 8 years, with Q3 2019 value amounting to $333334.0.

  • Incyte's Gains from Sales and Divestitures rose 2500.01% to $333334.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $333334.0, marking a year-over-year increase of 2500.01%. This contributed to the annual value of $266667.0 for FY2018, which is 3333.35% up from last year.
  • As of Q3 2019, Incyte's Gains from Sales and Divestitures stood at $333334.0, which was up 2500.01% from $333334.0 recorded in Q2 2019.
  • Incyte's Gains from Sales and Divestitures' 5-year high stood at $333334.0 during Q1 2019, with a 5-year trough of $133333.0 in Q4 2015.
  • In the last 5 years, Incyte's Gains from Sales and Divestitures had a median value of $266667.0 in 2018 and averaged $241025.8.
  • In the last 5 years, Incyte's Gains from Sales and Divestitures tumbled by 6328.72% in 2015 and then surged by 5000.04% in 2017.
  • Incyte's Gains from Sales and Divestitures (Quarter) stood at $133333.0 in 2015, then changed by 0.0% to $133333.0 in 2016, then soared by 50.0% to $200000.0 in 2017, then soared by 33.33% to $266667.0 in 2018, then rose by 25.0% to $333334.0 in 2019.
  • Its last three reported values are $333334.0 in Q3 2019, $333334.0 for Q2 2019, and $333334.0 during Q1 2019.